May 19, 2020 -- WuXi Biologics announced it has signed a deal with Worcester Business Development to build a clinical and commercial manufacturing facility in Worcester, MA.
The 107,000-sq-ft facility is expected to be completed in 2022. The location is the first U.S. biomanufacturing facility for WuXi. According to the company, the campus will be located on a 46-acre plot and will create 150 new jobs for the local economy.
WuXi is a Hong-Kong based drug discovery and clinical and commercial manufacturing organization. It currently has over 100 projects in phase I and II clinical development and 16 in phase III development, as well as one project in commercial manufacturing.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
